(Q37687429)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132063%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

review article

1 reference

title

Enhancing adoptive immunotherapy of cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132063%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132063%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Phillip K. Darcy

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132063%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Michael H. Kershaw

series ordinal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132063%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1

Jennifer A Westwood

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132063%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

5

Hollie J Pegram

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132063%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

3

Leanne Xj Wang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132063%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Linda J Berry

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132063%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

1 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132063%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Biological Therapy

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132063%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132063%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132063%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

531-545

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132063%20AND%20SRC:MED&resulttype=core&format=json

Studies on the immunological response to foreign tumor transplants in the mouse. I. The role of lymph node cells in conferring immunity by adoptive transfer

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Inhibition of established transplants of chemically induced sarcomas in syngeneic mice by lymphocytes from immunized donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Phase I study of the adoptive immunotherapy of human cancer with lectin activated autologous mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Adoptive cell therapy against EBV-related malignancies: a survey of clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Control of homeostasis of CD8+ memory T cells by opposing cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

IL-2, regulatory T cells, and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Guidelines for the safe administration of high-dose interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Combining adoptive cellular and immunocytokine therapies to improve treatment of B-lineage malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Comparison of common gamma-chain cytokines, interleukin-2, interleukin-7, and interleukin-15 for the in vitro generation of human tumor-reactive T lymphocytes for adoptive cell transfer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Interleukin-21: Basic Biology and Implications for Cancer and Autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Interleukin-21 augments the efficacy of T-cell therapy by eliciting concurrent cellular and humoral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Interleukin-7: from bench to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Incubation of antigen-sensitized T lymphocytes activated with bryostatin 1 + ionomycin in IL-7 + IL-15 increases yield of cells capable of inducing regression of melanoma metastases compared to culture in IL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Adoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Augmentation of cell-mediated immunotherapy against herpes simplex virus by interleukins: comparison of in vivo effects of IL-2 and IL-7 on adoptively transferred T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Interleukin-7 induced facilitation of immunological reconstitution of sublethally irradiated mice following treatment with alloreactive spleen cells in a murine model of B-cell leukemia/lymphoma (BCL1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Functions of γC cytokines in immune homeostasis: current and potential clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Transforming growth factor-beta receptor blockade augments the effectiveness of adoptive T-cell therapy of established solid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Enhancing antitumor immunity: combining IL-12 with TGFbeta1 antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Intralesional lymphokine-activated killer cells as adjuvant therapy for primary glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Adoptive transfer of tumor-primed, in vitro-activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitumor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

CD4 cells can be more efficient at tumor rejection than CD8 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

The central role of CD4(+) T cells in the antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Host-reactive CD8+ memory stem cells in graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Tumor-specific Th17-polarized cells eradicate large established melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Type 17 CD8+ T cells display enhanced antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

T lymphocytes isolated from patients with advanced colorectal cancer are suitable for gene immunotherapy approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Second-generation anti-carcinoembryonic antigen designer T cells resist activation-induced cell death, proliferate on tumor contact, secrete cytokines, and exhibit superior antitumor activity in vivo: a preclinical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Targeted elimination of prostate cancer by genetically directed human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Gene-engineered T cells as a superior adjuvant therapy for metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Transduction of an IL-2 gene into human melanoma-reactive lymphocytes results in their continued growth in the absence of exogenous IL-2 and maintenance of specific antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Bcl-2 overexpression enhances tumor-specific T-cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Immortalization of human CD8+ T cell clones by ectopic expression of telomerase reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Dual-specific T cells combine proliferation and antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Antitumor activity of dual-specific T cells and influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Targeting of tumor cells for human gammadelta T cells by nonpeptide antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Feasibility of the adoptive transfusion of allogenic human leukocyte antigen-matched natural killer cells in patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Inability to mediate prolonged reduction of regulatory T Cells after transfer of autologous CD25-depleted PBMC and interleukin-2 after lymphodepleting chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Homeostatic proliferation plus regulatory T-cell depletion promotes potent rejection of B16 melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Complete regression of advanced primary and metastatic mouse melanomas following combination chemoimmunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

CpG motifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Deliberately provoking local inflammation drives tumors to become their own protective vaccine site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Vascular targeting of anti-CD40 antibodies and IL-2 into autochthonous tumors enhances immunotherapy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Mechanisms of foxp3+ T regulatory cell-mediated suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Macrophage polarization in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Induced sensitization of tumor stroma leads to eradication of established cancer by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Cell transfer therapy for cancer: lessons from sequential treatments of a patient with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Intracavitary placement of autologous lymphokine-activated killer (LAK) cells after resection of recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Accumulation in tumor tissue of adoptively transferred T cells: A comparison between intravenous and intraperitoneal injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Genetic modification of T cells with IL-21 enhances antigen presentation and generation of central memory tumor-specific cytotoxic T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

An inducible caspase 9 safety switch for T-cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

Vascular normalization in Rgs5-deficient tumours promotes immune destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003610622

10.1517/14712591003610622

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132063%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference